DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026
Go back to DiaMedica Therapeutics to Report Fourth Quarter 2025 Financial Results and Provide a Business Update March 31, 2026| (NASDAQ: DMAC) | Delayed: 7.04 -0.18 (2.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $7.22 | 52 Week High | $ | |||
| Open | $7.21 | 52 Week Low | $ | |||
| Day High | $7.45 | P/E | N/A | |||
| Day Low | $7.01 | EPS | $ | |||
| Volume | 301,656 | |||||

